JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goethals, I.
Right arrow Articles by Van de Wiele, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goethals, I.
Right arrow Articles by Van de Wiele, C.
Journal of Nuclear Medicine Vol. 44 No. 9 1531-1539
© 2003 by Society of Nuclear Medicine


Special Contribution

The Role of Nuclear Medicine in the Prediction and Detection of Radiation-Associated Normal Pulmonary and Cardiac Damage

Ingeborg Goethals, MD1, Rudi Dierckx, MD, PhD1, Gert De Meerleer, MD, PhD2, Johan De Sutter, MD, PhD3, Olivier De Winter, MD1, Wilfried De Neve, MD, PhD2 and Christophe Van de Wiele, MD, PhD1

1 Division of Nuclear Medicine, University Hospital Ghent, Ghent, Belgium
2 Department of Radiotherapy, University Hospital Ghent, Ghent, Belgium
3 Department of Cardiology, University Hospital Ghent, Ghent, Belgium

Dose–effect calculations used in the planning of modern radiotherapy (RT) involving normal lung or cardiac tissue rely on structural imaging techniques, such as CT, as the basis for measuring and predicting dose–response. However, more accurate methods for predicting dose–response may result if information on the locoregional functional status of the irradiated organ(s) is included in the computational model. For RT cases that involve delivering dose to the lung and heart, this may be achieved by the assessment of tomographic scintigraphies of lung perfusion (Q) and ventilation (V) and scintigraphic imaging of myocardial perfusion and function, respectively.

Key Words: nuclear medicine • thoracic radiotherapy • adverse effects • prediction • monitoring







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2003 by the Society of Nuclear Medicine.